GGrantIndex
Sort

78,016 grants matching breast cancer

Consequences of Genomic Instability and Aneuploidy on the Colorectal Cancer

$555,767
Thomas Ried · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women

$555,727
Jennifer A. Doherty · University Of Utah · R01 · FY2016 · CA

Molecular Genomics of Breast Cancer

$555,707
Sergei R Malkhosyan · Sanford Burnham Prebys Medical Discovery Institute · R33 · FY2006 · CA

MAMMALIAN CELLS AND ECOSYSTEMS

$555,706
Thea D Tlsty · Princeton University · U54 · FY2012 · CA

Obesity Increases Breast Cancer Penetrance in BRCA Mutation Carriers: A Role for Local and Systemic Factors

$555,691
Andrew J Dannenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA

Development of A Multi-Modality System for Onco-Imaging

$555,660
Gultekin Gulsen · University Of California-Irvine · R33 · FY2010 · CA

In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy

$555,637
Craig Lewis Duvall · Vanderbilt University · R01 · FY2023 · CA

REDUCTION OF TRIGLYCERIDES IN WOMEN ON HRT

$555,615
University Of Pittsburgh At Pittsburgh · R01 · FY2003 · HL

GUAM BREAST, CERVICAL CANCER AND EARLY DETECTION PROGRAM

$555,578
J. Peter Roberto · Guam Department Of Public Health-Soc Svc · U58 · FY2009 · DP

Simultaneous Microwave and MR Imaging for Improved Diagnosis of Breast Abnormalities

$555,556
Keith D. Paulsen · Dartmouth College · R01 · FY2024 · CA

The Breast Cancer and the Workforce Communication App: A randomized controlled trial of an English/Spanish intervention to promote long-term job retention

$555,507
Victoria S Blinder · Sloan-Kettering Inst Can Research · R37 · FY2022 · CA

DUAL EPITHELIAL AND STROMAL TARGETING IN BREAST CANCER USING THE PHASE II ROCK2 INHIBITOR KD025 GUIDED BY INTRAVITAL IMAGING TECHNOLOGY

$555,506
University Of New South Wales · · FY2022 · Department of the Army

1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer

$555,499
William Joseph Murphy · University Of California At Davis · R01 · FY2017 · CA

Mapping the Pharmacogenetic Landscape for Precision Medicine

$555,492
Alan Ashworth · University Of California, San Francisco · U54 · FY2018 · CA

ProstaFluor FDA Trial for Real-Time Margin Detection During Prostatectomy

$555,491
David A. Benaron · Spectros Corporation · R01 · FY2012 · CA

A Novel Approach to Assessing Cryptogenic Stroke

$555,456
Frank R Sharp · University Of California At Davis · R01 · FY2014 · NS

Risk Prediction for Breast Cancer: A Tissue-Based Strategy

$555,452
Lynn C. Hartmann · Mayo Clinic Rochester · R01 · FY2012 · CA

CASE CONTROL SURVEILLANCE OF SERIOUS ILLNESSES AND DRUGS

$555,439
Boston University Medical Campus · R01 · FY2001 · CA

Multifrequency ultrasound imaging for improved breast tissue characterization

$555,370
Kenneth Hoyt · Texas Engineering Experiment Station · R01 · FY2023 · CA

Cancer Surveillance in HMO Administrative Data

$555,360
Healthpartners Research Foundation · R01 · FY2003 · CA

Therapy for Metastatic breast cancer based on micro RNA silencing

$555,309
Anna Moore · Michigan State University · R01 · FY2022 · CA

Effects of chronic pubertal stressors on mammary gland biology and cancer risk

$555,187
Matthew J Brady · University Of Chicago · R01 · FY2022 · CA

Integrated Biomarkers to Characterize Breast Cancer Risk

$555,114
Laura J Esserman · University Of California, San Francisco · U01 · FY2009 · CA

A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older

$555,111
Mara A Schonberg · Beth Israel Deaconess Medical Center · R01 · FY2023 · AG

Biology of Breast Cancers Arising in Older Women

$555,085
Buck Institute For Age Research · R01 · FY2004 · AG